Kitodac-DT Tablet contains Ketorolac 10 mg, a potent nonsteroidal anti-inflammatory drug (NSAID) indicated for the short-term management of moderate to severe acute pain. Ketorolac exerts its analgesic and anti-inflammatory effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, leading to decreased synthesis of prostaglandins, which are mediators of inflammation and pain. Kitodac-DT is commonly used postoperatively or for musculoskeletal pain where opioid analgesics are not preferred. The tablet formulation allows for rapid onset of action, providing effective pain relief. It is recommended for short-term use, typically not exceeding five days, due to the risk of adverse effects associated with prolonged NSAID therapy. Contraindications include active peptic ulcer disease, recent gastrointestinal bleeding, renal impairment, hypersensitivity to ketorolac or other NSAIDs, and patients at risk for bleeding complications. Caution is advised in patients with cardiovascular disease, hypertension, or hepatic dysfunction. Common side effects may include gastrointestinal discomfort, nausea, dizziness, and headache. Patients should avoid concomitant use with other NSAIDs or anticoagulants unless directed by a healthcare professional. Kitodac-DT should be used under medical supervision, adhering strictly to prescribed dosages to minimize risks and ensure optimal therapeutic outcomes.